Author

Raymond L. Benza

Observed names: R L Benza, Raymond Benza

Observed institutions: Mount Sinai Health System, Mount Sinai Hospital, Allegheny General Hospital, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5111738474

26-a-7952-acc Chronological Age and Responsiveness to Pulmonary Arterial Hypertension Therapies

2026 · Shaleen Thakur, Megan Griffiths, et al. · Journal of the American College of Cardiology

26-a-22803-acc Baseline Characteristics by Age in Fda Clinical Trial Pulmonary Arterial Hypertension Data

2026 · Shaleen Thakur, Megan Griffiths, et al. · Journal of the American College of Cardiology

Right ventricular voltage mapping predicts clinical performance in patients with pulmonary arterial hypertension

2025 · O Latif, S Bhuta, et al. · European Heart Journal

Sustained benefit with seralutinib treatment: Lessons from the open-label extension (OLE) of the TORREY study

2024 · Vallerie V. McLaughlin, Sidra Hoffman, et al. · European Respiratory Journal

Change In Diffusing Capacity For Carbon Monoxide As A Predictor Of Outcomes In Connective Tissue Disease Associated Pulmonary Arterial Hypertension: Analysis From The REVEAL Registry

2012 · Roham T. Zamanian, Kristina Kudelko, et al. · American Journal of Respiratory and Critical Care Medicine

Safety and efficacy of bosentan in combination with sildenafil in pulmonary arterial hypertension: The COMPASS-3 study

2011 · Fernando Torres, Himanshu Gupta, et al. · European Respiratory Journal

Works count: 6

Citation count:

H-index:

I10-index: